Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.
Condition:   Metastatic Castration-resistent Prostate Cancer Interventions:   Drug: Docetaxel;   Drug: Abiraterone Acetate or Enzalutamide Sponsor:   National Cancer Institute, Naples Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2019 Category: Research Source Type: clinical trials

Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer
Conditions:   Positive Lymph Node;   Prostate Adenocarcinoma;   PSA Level Greater Than Zero;   Stage I Prostate Cancer AJCC v8;   Stage II Prostate Cancer AJCC v8;   Stage IIA Prostate Cancer AJCC v8;   Stage IIB Prostate Cancer AJCC v8;   Stage IIC Prostate Cancer AJCC  v8;   Stage III Prostate Cancer AJCC v8;   Stage IIIA Prostate Cancer AJCC v8;   Stage I...
Source: ClinicalTrials.gov - October 22, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint Sponsors:   Johns Hopkins University;   Agendia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Conditions:   Transgender Women;   HIV/AIDS;   Cardiovascular Diseases;   Metabolic Disease;   Coagulopathy Interventions:   Other: Abdominal MR Imaging;   Other: Cardiac MRI/MRS;   Other: Oral Glucose Tolerance Testing;   Other: Whole Body, Lumbar Spine, and Hip DEXA Imaging Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
Conditions:   Anatomic Stage I Breast Cancer AJCC v8;   Anatomic Stage IIA Breast Cancer AJCC v8;   Anatomic Stage IA Breast Cancer AJCC v8;   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage III Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC  v8;   Anatomic Stage IIB Breast Cancer AJCC v8;   Anatomic Stage IIIB Breast Cancer A...
Source: ClinicalTrials.gov - September 12, 2019 Category: Research Source Type: clinical trials